Studies showed that the expressions or activities of most sirtuins in NAFLD were down-regulated 9 and CD38 was a key regulator in cardiovascular disease and metabolic syndrome through NAD+/Sirtuins signaling 10. Here, CD38 is linked to metabolic dysfunction-associated steatotic liver disease.